60 related articles for article (PubMed ID: 19035626)
1. ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer.
Ding L; Zou XJ; Ao JE; Yao AX; Cai L
Mol Diagn Ther; 2008; 12(6):395-400. PubMed ID: 19035626
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.
Mao C; Balasubramanian A; Yu M; Kiviat N; Ridder R; Reichert A; Herkert M; von Knebel Doeberitz M; Koutsky LA
Int J Cancer; 2007 Jun; 120(11):2435-8. PubMed ID: 17294450
[TBL] [Abstract][Full Text] [Related]
3. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
[TBL] [Abstract][Full Text] [Related]
4. An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions.
Huang MZ; Li HB; Nie XM; Wu XY; Jiang XM
Diagn Cytopathol; 2010 Aug; 38(8):573-8. PubMed ID: 19941368
[TBL] [Abstract][Full Text] [Related]
5. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
[TBL] [Abstract][Full Text] [Related]
7. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations.
Negri G; Egarter-Vigl E; Kasal A; Romano F; Haitel A; Mian C
Am J Surg Pathol; 2003 Feb; 27(2):187-93. PubMed ID: 12548164
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of enzyme-linked immunosorbent assay plasma p16INK4a protein in squamous cell carcinoma in uterine cervix: A case-control study.
Raju K; Raghuveer CV; Sheela SR; Natarajan A; Jagadish TV; Sunil BN; Sharat B
J Cancer Res Ther; 2022; 18(1):152-157. PubMed ID: 35381777
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of p16 based Double Antibody Sandwich ELISA for Detection of Cervical Precancer and Cancer.
Bose M; Sunder Singh S; Ganesharaja S; Chiwate AS; Hingmire SJ; Rajkumar T
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2337-2346. PubMed ID: 37505764
[TBL] [Abstract][Full Text] [Related]
11. Application of flow cytometry for biomarker-based cervical cancer cells detection.
Ling J; Wiederkehr U; Cabiness S; Shroyer KR; Robinson JP
Diagn Cytopathol; 2008 Feb; 36(2):76-84. PubMed ID: 18181189
[TBL] [Abstract][Full Text] [Related]
12. P16/CDKN2A and Ki-67 enhance the detection of anal intraepithelial neoplasia and condyloma and correlate with human papillomavirus detection by polymerase chain reaction.
Pirog EC; Quint KD; Yantiss RK
Am J Surg Pathol; 2010 Oct; 34(10):1449-55. PubMed ID: 20871219
[TBL] [Abstract][Full Text] [Related]
13. Correlation between indoleamine 2,3 dioxygenase mRNA and CDKN2A/p16 mRNA: a combined strategy to cervical cancer diagnosis.
Saffi Junior MC; Duarte ID; Brito RB; Prado GG; Makabe S; Dellê H; Camacho CP
Med Oncol; 2016 Nov; 33(11):132. PubMed ID: 27761872
[TBL] [Abstract][Full Text] [Related]
14. Performance of P16/Ki67 dual staining in triaging hr-HPV-positive population during cervical Cancer screening in the younger women.
Qian QP; Zhang X; Ding B; Jiang SW; Li ZM; Ren ML; Shen Y
Clin Chim Acta; 2018 Aug; 483():281-285. PubMed ID: 29758205
[TBL] [Abstract][Full Text] [Related]
15. Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
Samarawardana P; Singh M; Shroyer KR
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):514-8. PubMed ID: 21602668
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
17. HPV infection and p16
Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies.
Li Y; Wang W; Tian J; Zhou Y; Shen Y; Wang M; Tang L; Liu C; Zhang X; Shen F; Chen Y; Gu Y
Technol Cancer Res Treat; 2023; 22():15330338231202650. PubMed ID: 37968933
[No Abstract] [Full Text] [Related]
19. CDKN2A/p16 evaluation in cytology specimens.
Xing J; Griffith CC
Cancer Cytopathol; 2023 Nov; 131(11):672-676. PubMed ID: 37068112
[No Abstract] [Full Text] [Related]
20.
Sándor S; Tátrai K; Czeibert K; Egyed B; Kubinyi E
Front Vet Sci; 2021; 8():660435. PubMed ID: 33981746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
